NOURIN - Trademark Details
Status: 700 - Registered
Serial Number
88768088
Registration Number
6274061
Word Mark
NOURIN
Status
700 - Registered
Status Date
2021-02-16
Filing Date
2020-01-21
Registration Number
6274061
Registration Date
2021-02-16
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2020-06-09
Attorney Name
Law Office Assigned Location Code
L10
Employee Name
MAYES, LAURIE ANN
Statements
Goods and Services
protein arrays for research purposes; gene-based RNA molecular network being RNA sequences for research purposes; protein arrays for diagnosing of heart-related diseases angina, heart attack, cardiac and non-cardiac chest pain, heart failure, cardiovascular diseases, acute coronary syndromes, coronary artery disease, ischemic cardiac disease, subclinical or silent ischemia, low-grade myocardial ischemia, heart transplantation for cardiac allograft inflammation, monitor disease progression, severity of heart damage, risk assessment and prognosis, disease progression, myocardial cell damage, patients at-risk for coronary artery disease, and predict drug therapy response on heart tissue (myocardial cell damage) in clinical trials as well as other diseases, all of the foregoing for research purposes; gene-based RNA molecular network being RNA sequences for diagnosing of heart-related diseases angina, heart attack, cardiac and non-cardiac chest pain, heart failure, cardiovascular diseases, acute coronary syndromes, coronary artery disease, ischemic cardiac disease, subclinical or silent ischemia, low-grade myocardial ischemia, heart transplantation for cardiac allograft inflammation, monitor disease progression, severity of heart damage, risk assessment and prognosis, disease progression, myocardial cell damage, patients at-risk for coronary artery disease, and predict drug therapy response on heart tissue (myocardial cell damage) in clinical trials as well as other diseases, all of the foregoing for research use; diagnostic biomarker reagents for research purposes; protein arrays of biomarker reagents for research purposes; gene-based RNA molecular network biomarker reagents for research purposes; protein arrays and gene-based RNA molecular network biomarker reagents for research purposes; tissue-derived diagnostic biomarker reagents for research purposes; cardiac-derived diagnostic biomarker reagents for research purposes
Goods and Services
protein arrays for medical diagnosis purposes; gene-based RNA molecular network being RNA sequences for medical diagnosis purposes; protein arrays for diagnosing of heart-related diseases angina, heart attack, cardiac and non-cardiac chest pain, heart failure, cardiovascular diseases, acute coronary syndromes, coronary artery disease, ischemic cardiac disease, subclinical or silent ischemia, low-grade myocardial ischemia, heart transplantation for cardiac allograft inflammation, monitor disease progression, severity of heart damage, risk assessment and prognosis, disease progression, myocardial cell damage, patients at-risk for coronary artery disease, and predict drug therapy response on heart tissue (myocardial cell damage) in clinical trials as well as other diseases, all of the foregoing for medical diagnosis purposes; gene-based RNA molecular network being RNA sequences for diagnosing of heart-related diseases angina, heart attack, cardiac and non-cardiac chest pain, heart failure, cardiovascular diseases, acute coronary syndromes, coronary artery disease, ischemic cardiac disease, subclinical or silent ischemia, low-grade myocardial ischemia, heart transplantation for cardiac allograft inflammation, monitor disease progression, severity of heart damage, risk assessment and prognosis, disease progression, myocardial cell damage, patients at-risk for coronary artery disease, and predict drug therapy response on heart tissue (myocardial cell damage) in clinical trials as well as other diseases, all of the foregoing for medical use; diagnostic biomarker reagents for medical purposes; protein arrays of biomarker reagents for medical diagnosis purposes; gene-based RNA molecular network biomarker reagents for medical diagnosis purposes; protein arrays and gene-based RNA molecular network biomarker reagents for medical diagnosis purposes; tissue-derived diagnostic biomarker reagents for medical purposes; cardiac-derived diagnostic biomarker reagents for medical purposes
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2020-04-25
Primary Code
001
First Use Anywhere Date
2020-10-19
First Use In Commerce Date
2020-10-19
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-01-25
Primary Code
005
First Use Anywhere Date
2020-10-19
First Use In Commerce Date
2020-10-19
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Shuo Che Chou
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2020-01-24 | NEW APPLICATION ENTERED IN TRAM |
2020-01-25 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-04-08 | ASSIGNED TO EXAMINER |
2020-04-13 | NON-FINAL ACTION WRITTEN |
2020-04-13 | NON-FINAL ACTION E-MAILED |
2020-04-13 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-04-24 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-04-24 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-04-25 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-05-05 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-05-20 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-06-09 | PUBLISHED FOR OPPOSITION |
2020-06-09 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-08-04 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2020-12-22 | TEAS STATEMENT OF USE RECEIVED |
2021-01-13 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2020-12-22 | USE AMENDMENT FILED |
2021-01-14 | STATEMENT OF USE PROCESSING COMPLETE |
2021-01-14 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2021-01-15 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
2021-02-16 | REGISTERED-PRINCIPAL REGISTER |